Name: Anacetrapib
Price: Inquiry

- Overview
  - Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Ligands of Transporters
    
    Alternative Name
    
    (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4-fluoro-2-methoxy-5-(1-methylethyl)-4-(trifluoromethyl)[1,1-biphenyl]-2-yl]methy l]-4-methyl-2-oxazolidinone; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4-fluoro-5-isopropyl-2-methoxy-4-(triflu
    
    CAS Number
    
    875446-37-0
    
    Molecular Formula
    
    C30H25F10NO3
    
    Molecular Weight
    
    637.51 g/mol
    
    MDL Number
    
    MFCD16294903
    
    Note
    
    There is a hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Ranalletta et al (2010). Biochemical characterization of cholesteryl ester transfer protein inhibitors. Journal of Lipid Research, 51(9):2739-52.
    HPS3/TIMI55–REVEAL Collaborative Group et al (2017). Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. The New England Journal of Medicine, 377(13):1217-1227.
    Filippatos TD et al (2017). Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias? Diseases, 5(4). pii: E21.